<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, we also recently showed that the same treatment improved the laboratory data of 2 mitochondrial disease patients, one with mitochondrial cardiomyopathy and the other with mitochondrial diabetes, and brain natriuretic peptide (BNP) decreased by 31% in the former patient, and in the latter, insulinogenic index increased by 3.1 fold.
 <sup>[
  <xref rid="R63" ref-type="bibr">63</xref>]
 </sup> Taken together, these data suggest that our treatment may improve disorders induced by cellular ATP shortage, which can be considered a reason for the abnormalities found in mitochondrial disease patients.
 <sup>[
  <xref rid="R64" ref-type="bibr">64</xref>]
 </sup>
</p>
